Bactiquant AS (CO:BACTIQ) — Stock Price
Bactiquant AS (CO:BACTIQ) is currently trading at Dkr2.30 DKK, up 1.77% today. Over the past 52 weeks, shares have ranged between Dkr2.12 and Dkr3.95. This page tracks Bactiquant AS's live share price on the CO exchange, its daily price and volume history, and — where reported — its income statement, balance sheet, cash flow statement, and earnings history. For company valuation and market capitalisation context, see how much is Bactiquant AS worth.
Bactiquant AS (BACTIQ) Stock Price Chart — Daily History & Trading Volume
The chart below tracks Bactiquant AS's daily closing share price and trading volume on the CO exchange over the past year, giving a clear view of recent price momentum and liquidity.
Bactiquant AS Income Statement — Revenue, Profit & Earnings by Year
Bactiquant AS's annual income statement shows how revenue converts into profit each fiscal year, including gross profit, operating income, EBITDA, and net income.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total Revenue | Dkr8.32 Million | Dkr7.18 Million | Dkr12.30 Million | Dkr12.39 Million | Dkr8.36 Million |
| Cost of Revenue | Dkr19.76 Million | Dkr18.76 Million | Dkr13.06 Million | Dkr25.18 Million | Dkr20.31 Million |
| Gross Profit | Dkr-11.44 Million | Dkr-11.58 Million | Dkr-755.71K | Dkr-12.79 Million | Dkr-11.95 Million |
| Research & Development | Dkr1.06 Million | Dkr1.06 Million | — | Dkr888.26K | Dkr727.78K |
| SG&A | — | — | — | Dkr11.19 Million | Dkr8.85 Million |
| Total Operating Expenses | Dkr1.09 Million | Dkr1.06 Million | Dkr10.15 Million | Dkr-26.07 Million | Dkr727.78K |
| Operating Income | Dkr-12.52 Million | Dkr-12.64 Million | Dkr-10.90 Million | Dkr-13.68 Million | Dkr-12.68 Million |
| EBITDA | Dkr-12.01 Million | Dkr-11.71 Million | Dkr-11.12 Million | Dkr-13.18 Million | Dkr-12.46 Million |
| EBIT | Dkr-12.52 Million | Dkr-12.28 Million | Dkr-11.58 Million | Dkr-13.63 Million | Dkr-12.61 Million |
| Interest Expense | Dkr1.43 Million | Dkr1.44 Million | Dkr1.52 Million | Dkr700.61K | Dkr826.97K |
| Income Before Tax | Dkr-13.83 Million | Dkr-13.72 Million | Dkr-13.10 Million | Dkr-14.18 Million | Dkr-13.43 Million |
| Income Tax Expense | — | — | — | Dkr192.73K | Dkr118.73K |
| Net Income | Dkr-13.83 Million | Dkr-13.72 Million | Dkr-13.10 Million | Dkr-14.18 Million | Dkr-13.55 Million |
Bactiquant AS Balance Sheet — Assets, Liabilities & Shareholder Equity
The balance sheet below summarizes Bactiquant AS's financial position at each fiscal year-end — what it owns (assets), what it owes (liabilities), and the resulting shareholder equity.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total Assets | Dkr28.07 Million | Dkr14.70 Million | Dkr25.50 Million | Dkr23.18 Million | Dkr24.52 Million |
| Total Current Assets | Dkr23.54 Million | Dkr8.60 Million | Dkr18.11 Million | Dkr14.96 Million | Dkr15.73 Million |
| Cash & Equivalents | — | — | — | — | — |
| Short-term Investments | — | — | — | — | — |
| Net Receivables | Dkr1.71 Million | Dkr3.26 Million | Dkr2.46 Million | Dkr7.32 Million | Dkr2.15 Million |
| Inventory | Dkr3.96 Million | Dkr4.34 Million | Dkr3.72 Million | Dkr3.41 Million | Dkr3.00 Million |
| Property, Plant & Equipment | — | — | — | — | — |
| Goodwill | — | — | — | — | — |
| Total Liabilities | Dkr10.81 Million | Dkr14.01 Million | Dkr11.09 Million | Dkr8.87 Million | Dkr3.46 Million |
| Total Current Liabilities | Dkr3.91 Million | Dkr5.52 Million | Dkr2.65 Million | Dkr4.16 Million | Dkr2.41 Million |
| Long-term Debt | Dkr6.77 Million | Dkr8.49 Million | Dkr8.44 Million | Dkr4.71 Million | Dkr1.04 Million |
| Net Debt | Dkr-9.64 Million | Dkr9.93 Million | Dkr-3.39 Million | Dkr1.10 Million | Dkr-8.89 Million |
| Total Stockholder Equity | Dkr17.26 Million | Dkr689.23K | Dkr14.41 Million | Dkr14.31 Million | Dkr21.06 Million |
| Retained Earnings | Dkr14.06 Million | Dkr-1.48 Million | Dkr11.56 Million | Dkr12.57 Million | Dkr19.36 Million |
Bactiquant AS Cash Flow Statement — Operating, Investing & Financing Activities
This cash flow statement breaks down how Bactiquant AS generates and spends cash across operating, investing, and financing activities each fiscal year, including free cash flow and capital expenditures.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating Cash Flow | Dkr-10.51 Million | Dkr-12.63 Million | Dkr-8.16 Million | Dkr-17.10 Million | Dkr-13.25 Million |
| Capital Expenditures | Dkr4.00 | Dkr335.15K | Dkr540.55K | Dkr757.49K | Dkr2.19 Million |
| Free Cash Flow | Dkr-10.51 Million | Dkr-12.97 Million | Dkr-8.70 Million | Dkr-17.85 Million | Dkr-15.44 Million |
| Investing Cash Flow | Dkr-9.00K | Dkr-343.98K | Dkr-581.80K | Dkr-767.61K | Dkr-2.59 Million |
| Financing Cash Flow | Dkr27.53 Million | Dkr2.00 Million | Dkr16.95 Million | Dkr11.04 Million | Dkr25.61 Million |
| Dividends Paid | — | — | — | — | — |
| Stock-Based Compensation | — | — | — | — | — |
| Depreciation | Dkr514.93K | Dkr577.06K | Dkr459.88K | Dkr1.73 Million | Dkr267.89K |
| Change in Cash | Dkr17.01 Million | Dkr-10.97 Million | Dkr8.21 Million | Dkr-6.82 Million | Dkr9.77 Million |
Bactiquant AS Earnings History — EPS Actual vs. Analyst Estimates
Track Bactiquant AS's quarterly earnings per share (EPS) against Wall Street estimates, along with the earnings surprise percentage for each reporting period.
| Report Date | EPS Actual | EPS Estimate | Surprise |
|---|---|---|---|
| Apr 17, 2025 | — | — | — |
| Mar 15, 2023 | -0.39 | 0.00 | — |
| Sep 19, 2022 | -0.37 | 0.00 | — |
| Mar 14, 2022 | -0.52 | 0.00 | — |
| Aug 18, 2021 | -0.04 | 0.00 | — |
| Mar 11, 2021 | -0.02 | 0.00 | — |